DocDollars

Medtronic Vascular, Inc.

MN · United States · Reporting entity ID 100000010384

Total reported 2019–2025
$235.1M
#51 of 2,960 reporting companies — 0.3% of all reported industry payments
$144.3M in general payments across 201,596 records, plus $90.8M in research funding across 16,105 records.

How it breaks down

General payments $144,337,791
Research funding $90,784,938

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Medtronic Vascular, Inc. reported $235.1M to US doctors and teaching hospitals from 2019 to 2025, ranking #51 of 2,960 reporting companies. 39% of that was research funding and 61% general payments such as consulting, speaking, food and travel. 201,596 general payment records and 16,105 research records were filed.

Common questions about Medtronic Vascular, Inc.

How much has Medtronic Vascular, Inc. paid US doctors?

Medtronic Vascular, Inc. reported $235,122,729 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $144,337,791 in general payments, $90,784,938 in research funding.

How does Medtronic Vascular, Inc. rank among drug and device companies?

It ranks #51 of 2,960 reporting entities by total reported value, about 0.3% of all industry payments in the dataset.

Does a payment from Medtronic Vascular, Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.